83 related articles for article (PubMed ID: 20599598)
1. Toxicokinetics of tabun enantiomers in anaesthetized swine after intravenous tabun administration.
Tenberken O; Mikler J; Hill I; Weatherby K; Thiermann H; Worek F; Reiter G
Toxicol Lett; 2010 Oct; 198(2):177-81. PubMed ID: 20599598
[TBL] [Abstract][Full Text] [Related]
2. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase.
Tenberken O; Thiermann H; Worek F; Reiter G
Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a sensitive gas chromatography-ammonia chemical ionization mass spectrometry method for the determination of tabun enantiomers in hemolysed blood and plasma of different species.
Tenberken O; Worek F; Thiermann H; Reiter G
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1290-6. PubMed ID: 19766064
[TBL] [Abstract][Full Text] [Related]
4. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
[TBL] [Abstract][Full Text] [Related]
5. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs.
Spruit HE; Langenberg JP; Trap HC; van der Wiel HJ; Helmich RB; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 2000 Dec; 169(3):249-54. PubMed ID: 11133347
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
Reiter G; Müller S; Hill I; Weatherby K; Thiermann H; Worek F; Mikler J
Toxicol Lett; 2015 Jan; 232(2):438-48. PubMed ID: 25448275
[TBL] [Abstract][Full Text] [Related]
8. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes.
Ekström FJ; Astot C; Pang YP
Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
11. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
13. Fixation of the two Tabun isomers in acetylcholinesterase: a QM/MM study.
Kwasnieski O; Verdier L; Malacria M; Derat E
J Phys Chem B; 2009 Jul; 113(29):10001-7. PubMed ID: 19569635
[TBL] [Abstract][Full Text] [Related]
14. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
[TBL] [Abstract][Full Text] [Related]
15. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
16. Development and application of procedures for the highly sensitive quantification of cyclosarin enantiomers in hemolysed swine blood samples.
Reiter G; Koller M; Thiermann H; Dorandeu F; Mikler J; Worek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):9-15. PubMed ID: 17888747
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
[TBL] [Abstract][Full Text] [Related]
18. Structural evidence that human acetylcholinesterase inhibited by tabun ages through O-dealkylation.
Carletti E; Colletier JP; Dupeux F; Trovaslet M; Masson P; Nachon F
J Med Chem; 2010 May; 53(10):4002-8. PubMed ID: 20408548
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
